Literature DB >> 12041664

Signal transduction-associated and cell activation-linked antigens expressed in human mast cells.

Peter Valent1, Minoo Ghannadan, Alexander W Hauswirth, Gerit-Holger Schernthaner, Wolfgang R Sperr, Michel Arock.   

Abstract

Mast cells (MCs) are multifunctional hematopoietic effector cells that produce and release an array of biologically active mediator substances. Growth and functions of MCs are regulated by cytokines, other extracellular factors, surface and cytoplasmic receptors, oncogene products, and a complex network of signal transduction cascades. Key regulators of differentiation of MCs appear to be stem cell factor (SCF) and its tyrosine kinase receptor KIT (c-kit proto-oncogene product=CD117), downstream-acting elements, and the mi transcription factor (MITF). Signaling through KIT is negatively regulated by the signal regulatory protein (SIRP)-alpha (CD172a)-SHP-1-pathway that is disrupted in neoplastic MCs in MC proliferative disorders. Both KIT and FcepsilonRI are involved in MC activation and mediator release. Activation of MCs through FcepsilonRI is associated with increased expression of activation-linked membrane antigens as well as with signaling events involving Lyn and Syk kinases, the phosphatidylinositol-3-kinase-pathway, Ras pathway, and the phospholipase C-protein kinase C pathway. A similar network of signaling is found in SCF-activated MCs. The current article gives an overview on signal transduction-associated and activation-linked antigens expressed in human MCs. Wherever possible the functional implication of signaling pathways and antigen expression are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12041664     DOI: 10.1007/bf02982124

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  59 in total

Review 1.  Kit signal transduction.

Authors:  M L Taylor; D D Metcalfe
Journal:  Hematol Oncol Clin North Am       Date:  2000-06       Impact factor: 3.722

Review 2.  The riddle of the mast cell: kit(CD117)-ligand as the missing link?

Authors:  P Valent
Journal:  Immunol Today       Date:  1994-03

3.  Induction of the high-affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4.

Authors:  H Toru; C Ra; S Nonoyama; K Suzuki; J Yata; T Nakahata
Journal:  Int Immunol       Date:  1996-09       Impact factor: 4.823

4.  Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells.

Authors:  H Z Xia; Z Du; S Craig; G Klisch; N Noben-Trauth; J P Kochan; T H Huff; A M Irani; L B Schwartz
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

Review 5.  c-Kit and c-kit mutations in mastocytosis and other hematological diseases.

Authors:  M Boissan; F Feger; J J Guillosson; M Arock
Journal:  J Leukoc Biol       Date:  2000-02       Impact factor: 4.962

Review 6.  The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.

Authors:  S J Galli; M Tsai; B K Wershil
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

7.  Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.

Authors:  B J Longley; L Tyrrell; S Z Lu; Y S Ma; K Langley; T G Ding; T Duffy; P Jacobs; L H Tang; I Modlin
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

8.  Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor.

Authors:  H Kihara; R P Siraganian
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

9.  Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor.

Authors:  M H Jouvin; M Adamczewski; R Numerof; O Letourneur; A Vallé; J P Kinet
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

10.  Negative regulation of Fc epsilon RI-mediated degranulation by CD81.

Authors:  T J Fleming; E Donnadieu; C H Song; F V Laethem; S J Galli; J P Kinet
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.